Discovering new drugs is an expensive proposition. From 2012 to 2022, adjusting for inflation, spending on pharmaceutical research and development increased by almost half to roughly $250bn, according ...

Developing high-quality, safe, and effective drugs is a complex process that requires varied scientific skills and stringent regulatory assessments. Drug development is a process that spans many years ...

The world of medicine has taken a significant leap forward with the first AI-generated drug entering clinical trials. This ...

Artificial Intelligence Accelerates Target Discovery and Clinical Trials Traditional drug development faces challenges of long cycles and high costs, and the involvement of artificial intelligence ...

Demis Hassabis, CEO of DeepMind, revealed that AI can drastically shorten drug discovery timelines, potentially reducing ...

The compounds that emerge aren't just theoretical curiosities. They're synthesised and tested, and one targeting fibrosis ...

Southwest Research Institute scientists developed a new purification technique to improve chromatography results without expensive purification materials or equipment. Chromatography is an essential ...

The global drug discovery services market is projected to grow at a CAGR of 15% from 2025 to 2030. This growth is driven by ...

AlphaFold, a transformative AI-driven tool developed by DeepMind, has revolutionized the field of structural biology by accurately predicting protein structures. This breakthrough holds significant ...

SandboxAQ is a company that many pharma and biotech professionals will be keeping an extremely close eye on in the coming years. Having SandboxAQ emerged as an independent company following spin-off ...

The Drug Discovery Outsourcing Market is set to grow at a 7.2% CAGR, driven by advanced technologies and increased demand for specialized expertise. NEWARK, DE, UNITED STATES, September 11, 2025 ...